| Typicality: | 0.548 |
| Saliency: | 0.320 |
| each year | 6 | temporal |
| to test these products | 3 | purpose |
| by amgen | 2 | other |
| medicine → be sold in → the u.s. | 7 |
| medicine → be purchased in → the united states | 6 |
| medicine → be marketed in → the united states | 3 |
| medicine → be marketed in → the u.s. | 3 |
| negative | neutral | positive |
| 0.106 | 0.726 | 0.168 |
| Raw frequency | 19 |
| Normalized frequency | 0.320 |
| Modifier score | 1.000 |
| Perplexity | 31.680 |